A new editorial paper was published in Oncoscience and is titled “HER2 expression should be routinely evaluated in DCIS to avoid under or overtreatment!”
HER2 is more frequently…
in Health
A case for routine evaluation of HER2 expression in ductal carcinoma in situ
